Evidence map›Paper›PMID 38812720›Full record

ArticleSchizophrenia bulletin open2023

Auditory Cortex Thickness Is Associated With N100 Amplitude in Schizophrenia Spectrum Disorders.

Nora Berz Slapø, Stener Nerland, Kjetil Nordbø Jørgensen, Lynn Mørch-Johnsen, Johanne Hagen Pettersen, Daniel Roelfs, Nadine Parker, Mathias Valstad, Atle Pentz, Clara M F Timpe and 12 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Schizophrenia bulletin open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Nora Berz SlapøDepartment of medicine, NORMENT, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.ORCID https://orcid.org/0000-0001-9360-8610
Stener NerlandDepartment of medicine, NORMENT, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Kjetil Nordbø JørgensenDepartment of medicine, NORMENT, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Lynn Mørch-JohnsenNORMENT, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
Johanne Hagen PettersenDepartment of Mental Disorders, Norwegian Institute of Public Health, Oslo, Norway.
Daniel RoelfsDepartment of medicine, NORMENT, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Nadine ParkerDepartment of medicine, NORMENT, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Mathias ValstadDepartment of medicine, NORMENT, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Atle PentzDepartment of medicine, NORMENT, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Clara M F TimpeDepartment of medicine, NORMENT, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Geneviève RichardDepartment of medicine, NORMENT, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Dani BeckDepartment of medicine, NORMENT, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Maren C Frogner WernerDepartment of medicine, NORMENT, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Trine Vik LagerbergDepartment of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway.
Ingrid MelleDepartment of medicine, NORMENT, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Ingrid AgartzDepartment of Psychiatry, Telemark Hospital, Skien, Norway.
Lars T WestlyeDepartment of medicine, NORMENT, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.ORCID https://orcid.org/0000-0001-8644-956X
Nils Eiel SteenDepartment of medicine, NORMENT, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.ORCID https://orcid.org/0000-0001-6442-1179
Ole A AndreassenDepartment of medicine, NORMENT, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Torgeir MobergetDepartment of medicine, NORMENT, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Torbjørn ElvsåshagenDepartment of medicine, NORMENT, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Erik G JönssonDepartment of medicine, NORMENT, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Funding

European Research Council 802998
6 · The paper itself

Abstract

Background and Hypothesis: The auditory cortex (AC) may play a central role in the pathophysiology of schizophrenia and auditory hallucinations (AH). Previous schizophrenia studies report thinner AC and impaired AC function, as indicated by decreased N100 amplitude of the auditory evoked potential. However, whether these structural and functional alterations link to AH in schizophrenia remain poorly understood. Study Design: Patients with a schizophrenia spectrum disorder (SCZ Study Results: N100 amplitude was nominally smaller in SCZ Conclusions: The novel findings of positive associations between AC thickness and N100 amplitude in SCZ

Indexed as

auditory hallucinationsbrain functionbrain structureEEGevent-related potentialsMRIpsychosis

Identifiers

PMID38812720
PMCPMC7616042

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.